$CGEM
Price history, market instrument context, member research, and related headlines in one place.
CGEM key statistics
NasdaqGSUSD
52-week range
$6.7342%$23.19
Latest session $13.44–$14.18Cullinan Therapeutics, Inc. (CGEM) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $13.64, down $0.46 (3.26%) from the previous close of $14.10. It has traded between $13.44 and $14.18 in the latest session. Over the past year it has ranged from $6.73 to $23.19, leaving it around the middle of its 52-week range (42%). Reported volume for the session was 903.1K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Cullinan rises as lung cancer drug succeeds in late-stage trial — See source for full details.
Cullinan Oncology earnings up next: Can pipeline justify cash burn? — See source for full details.
Loading $CGEM research…